The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes

Research output: Contribution to journalJournal article

Original languageEnglish
JournalJournal of Clinical Endocrinology and Metabolism
Issue number90
Pages (from-to)4888-4894
ISSN0021-972X
Publication statusPublished - 2005

ID: 70520